0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Botulism Surveillance and Emergency Response:  A Public Health Strategy for a Global Challenge

Roger L. Shapiro, MD; Charles Hatheway, PhD; John Becher, RPH; David L. Swerdlow, MD
JAMA. 1997;278(5):433-435. doi:10.1001/jama.1997.03550050095041.
Text Size: A A A
Published online

Botulism is a neuroparalytic disease caused by a neurotoxin produced from an anaerobic spore-forming bacterium known as Clostridium botulinum.1 The lethal potency of this toxin has mandated intensive surveillance and control measures in the United States. Recent outbreaks of botulism have raised questions regarding the international supply and therapeutic use of botulism antitoxin, and reports that national governments2 and terrorist groups3 have stockpiled botulism toxin have increased levels of concern regarding global preparedness for an intentional episode of botulism poisoning. It is estimated that as little as 1 g of aerosolized botulism toxin has the potential to kill at least 1.5 million people, and modern techniques of aerosolization via tactical ballistic missiles or aeronautical spraying may be capable of disseminating up to 60% of this dosage to a target population.4

A description of the clinical features of aerosolized botulism toxin poisoning appears elsewhere in this issue.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();